<code id='77107285FC'></code><style id='77107285FC'></style>
      • <acronym id='77107285FC'></acronym>
      <center id='77107285FC'><center id='77107285FC'><tfoot id='77107285FC'></tfoot></center><abbr id='77107285FC'><dir id='77107285FC'><tfoot id='77107285FC'></tfoot><noframes id='77107285FC'>
      • <optgroup id='77107285FC'><strike id='77107285FC'><sup id='77107285FC'></sup></strike><code id='77107285FC'></code></optgroup>
        5. <b id='77107285FC'><label id='77107285FC'><select id='77107285FC'><dt id='77107285FC'><span id='77107285FC'></span></dt></select></label></b><u id='77107285FC'></u>
          <i id='77107285FC'><strike id='77107285FC'><tt id='77107285FC'><pre id='77107285FC'></pre></tt></strike></i>
           
   
   
   
 

  
           
   
           
    
           
     
          
       Home / hotspot / explore      
           
     
           
      
          explore 
           
      
           
      
           
       2025-09-28 03:08:25 
   
      
           
      
           
                        
          explore  
          
                                   
                 
                                      author：fashion   
                                        
                                      
                                      Page View：72
                                  
                                    
          
                                   
          Alexis Borisy
          Venture capitalist Alexis Borisy																									Vanessa Leroy for STAT
          EQRx is done, sold for its cash.
          The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.
          advertisement
          The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.
          Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!					
          GET STARTED													Log In											
                      
                              
          
                                 Previous article：

                                
                                          Flagship Pioneering startup Sonata Therapeutics lays off 21
                                
                            
          Next article：  
                                      
                                          Alkermes shareholders re
                                                                    
          

      
           
    


       
       
       
    
     
           
    
           
    
           
   
      
     
           
      
           
       
          Related articles